EUVIMED · CrossrefJournal
Therapeutic Advances in Medical Oncology
ISSN 1758-8359 · SAGE Publications
Latest articles
Plasma metabolomic profiling to predict durable response and survival with afatinib in EGFR-mutated non-small cell lung cancer: A prospective, multicenter, observational biomarker study
From genomics to clinic: Guiding venetoclax-based therapy in AML via molecular determinants and risk models
The evolving management of patients with extensive-stage small cell lung cancer in Switzerland: From regulatory access to bedside
Muscle and tissue radiodensity matter: Automated CT-based body composition analysis predicts survival in hepatocellular carcinoma patients undergoing degradable starch microspheres transarterial chemoembolization (DSM-TACE)
The BCLC-CRAFITY model as a novel efficacy predictor for hepatocellular carcinoma treated with curative radiofrequency ablation followed by adjuvant immunotherapy: A retrospective cohort study
The role of PD-L2 within the PD-1-driven axis in NSCLC: From molecular mechanisms to clinical translation
Real-world treatment patterns and outcomes during and after treatment with CDK4/6 inhibitors for HR-positive and HER2-negative metastatic breast cancer
The tumor stroma ratio in stage II and III colon cancer: Prognostic impact and evaluation of predictive value
Comparison of efficacy and safety of GP to PX induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: A Propensity Score–Matched analysis
Atypical response and progression patterns in advanced non-small cell lung cancer receiving immunochemotherapy or chemotherapy: A post hoc analysis of CHOICE-01
Chemotherapy-induced peripheral neuropathy (CIPN): Disease mechanisms, experimental models and emerging prevention strategies
Safety and efficacy of TROP2-directed ADCs in HER2-negative breast cancer: A systematic review and network meta-analysis
A quantitative trigger model to enable personalized adaptive radiotherapy in nasopharyngeal carcinoma
Serum angiopoietin-like protein 4 concentration as a predictive biomarker for immunotherapy response in hepatocellular carcinoma
Real-world outcomes of caucasians with EGFR -mutated non-small-cell lung cancer treated with surgery (EXERPOS-2 GFPC study)
Which ARPI first in chemotherapy-naïve mCRPC? Enzalutamide versus abiraterone: A nationwide real-world study
HLX07, a novel anti-EGFR antibody, for locally advanced and metastatic cutaneous squamous cell carcinoma: an open-label, multicenter, phase II trial
Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer
Guideline recommendations versus real-world management in early-stage testicular cancer: a multicenter survey of contemporary practice
Long-term comparative effectiveness of tepotinib versus standard of care for MET exon 14 skipping-mutated non-small cell lung cancer
Prognostic performance of a novel multiplex circulating tumor DNA assay for lung cancer outcomes
Development and external validation of two nomograms for predicting brain metastases and brain metastasis-free survival in primary small cell carcinoma of the esophagus: a retrospective multicenter analysis
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33—REGAL study
Comparison of the efficacy and safety of HLX-02 plus pertuzumab versus HLX-02 plus pyrotinib in neoadjuvant therapy for HER2-positive breast cancer
Lung-molGPA may stratify the prognostic impact of TP53 co-mutation in EGFR-mutant lung adenocarcinoma with brain metastases: a multi-center retrospective analysis
Biomarker testing in advanced or metastatic hormone receptor-positive, human epidermal growth factor receptor 2 negative breast cancer: expert recommendations
Real-world analysis of perioperative strategies for driver gene-positive resectable non-small cell lung cancer
Historical evaluation of clinical outcomes and safety following isolated limb perfusion for unresectable melanoma: Real-world data from the Mannheim Cancer Center
Timing of immune checkpoint inhibitor infusion predicts survival in advanced esophageal squamous cell carcinoma: A retrospective cohort study
Lung cancer across borders: From molecular epidemiology to precision treatment strategies
EUVIMED